Physician
Ryan, Mark
Ryan, Mark was paid $268K by Medicaid between Feb 2018 and Dec 2022, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoRYAN, MARK
MILFORD, MA 01757
MILFORD, MA 01757
33aNPI1881629871assigned 07/11/2006
33bProvider typePediatrics Physician
28Total paid$268K
24GClaims7,541
24DCodes billed23
24AFirst – last monthFeb 2018 – Dec 2022
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#235 of 1,273
Median peer was paid$24K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,145 | $37K | |
| 2019 | 1,599 | $53K | |
| 2020 | 1,337 | $48K | |
| 2021 | 1,509 | $51K | |
| 2022 | 1,951 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 1,297 | 1,268 | $75K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 616 | 602 | $54K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 17% | 1,351 | 1,079 | $44K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 5.4% | 1,605 | 1,598 | $15K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.3% | 110 | 110 | $14K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.1% | 392 | 384 | $11K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.0% | 125 | 125 | $11K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.5% | 897 | 896 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 106 | 106 | $9K |
| 90461 | 2.4% | 173 | 173 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 32 | 31 | $5K |
| 96127 | 1.3% | 342 | 341 | $4K |
11 more codes
| 99173 | <1% | 117 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 57 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 136 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 28 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 63 | $1K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $936.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 25 | $511.25 |
| 99051 | <1% | 16 | $264.96 | |
| 92551 | <1% | 12 | $104.16 | |
| 85018 | <1% | 15 | $32.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.